Identification of risk factors for retinal vascular events in a population-based cross-sectional study in Rumoi, Japan.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 03 2021
Historique:
received: 27 11 2020
accepted: 04 03 2021
entrez: 19 3 2021
pubmed: 20 3 2021
medline: 13 10 2021
Statut: epublish

Résumé

We conducted a population-based, cross-sectional study in Japan to identify risk factors for retinal vascular events separately by gender. Forty years or older participants were recruited. Fundus photographs were taken, and lifestyle and health characteristics were determined through a questionnaire and physical examinations. We compared the group of those who had retinal vascular events and those who did not. A total of 1689 participants (964 men) were deemed eligible for the study and retinal vascular events were seen in 59 subjects (3.7% of the men, 3.2% of the women). Self-reported diabetes mellitus was significantly associated with the vascular events in each gender [odds ratio (OR) = 6.97, 6.19 (men, women); 95% confidence interval (CI) 3.02-15.9, 2.25-17.0; p < 0.001]. Higher systolic blood pressure (OR = 1.03; 95% CI 1.01-1.04; p = 0.006) and lower frequency of meat consumption (OR = 0.73; 95% CI 0.54-0.99; p = 0.04) were independently associated with the vascular events in men. In women, while vascular events were associated with self-reported hypertension (OR = 2.64; 95% CI 1.03-6.74; p = 0.04), no association was seen with systolic blood pressure. Women with hypertension may need extra care, not only for blood pressure.

Identifiants

pubmed: 33737584
doi: 10.1038/s41598-021-85655-y
pii: 10.1038/s41598-021-85655-y
pmc: PMC7973805
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6340

Références

Arch Intern Med. 2009 Mar 23;169(6):562-71
pubmed: 19307518
JAMA. 2005 Jan 5;293(1):63-9
pubmed: 15632337
Acta Ophthalmol. 2014 Jun;92(4):316-22
pubmed: 23901899
Stroke. 2012 Oct;43(10):2556-60
pubmed: 22851546
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5905-9
pubmed: 21693603
PLoS One. 2018 Oct 2;13(10):e0204955
pubmed: 30278082
Retina. 2019 Jun;39(6):1206-1215
pubmed: 29533284
Circulation. 2010 Jun 1;121(21):2271-83
pubmed: 20479151
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Prog Retin Eye Res. 2017 Sep;60:20-43
pubmed: 28864288
J Stroke Cerebrovasc Dis. 2016 May;25(5):1177-1186
pubmed: 26935118
PLoS One. 2013;8(2):e56963
pubmed: 23451121
J Clin Hypertens (Greenwich). 2019 Dec;21(12):1895-1904
pubmed: 31661601
Br J Ophthalmol. 2008 Feb;92(2):161-6
pubmed: 17965107
Trans Am Ophthalmol Soc. 2006;104:98-107
pubmed: 17471330
Arch Ophthalmol. 1998 Jan;116(1):83-9
pubmed: 9445212
Ophthalmology. 2003 Apr;110(4):658-66
pubmed: 12689883
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3205-9
pubmed: 20071683
Hypertens Res. 2019 Sep;42(9):1235-1481
pubmed: 31375757
Am J Ophthalmol. 2009 May;147(5):934-44, 944.e1-2
pubmed: 19243735
JAMA. 2002 Jul 3;288(1):67-74
pubmed: 12090864
Arch Ophthalmol. 2010 Dec;128(12):1568-75
pubmed: 21149781

Auteurs

Reiko Kinouchi (R)

Medicine and Engineering Combined Research Institute, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan. rkino@asahikawa-med.ac.jp.
Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan. rkino@asahikawa-med.ac.jp.

Satoshi Ishiko (S)

Medicine and Engineering Combined Research Institute, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.

Kazuomi Hanada (K)

Medicine and Engineering Combined Research Institute, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.
Asari Chuo Hospital, Hokkaido, Japan.

Hiroki Hayashi (H)

Medicine and Engineering Combined Research Institute, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.

Daiki Mikami (D)

Medicine and Engineering Combined Research Institute, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa, 078-8510, Japan.

Akitoshi Yoshida (A)

Department of Ophthalmology, Asahikawa Medical University, Asahikawa, Hokkaido, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH